By Charlie Innis ( March 21, 2022, 5:46 PM EDT) -- AN2 Therapeutics, a biopharmaceutical startup developing treatment for a rare form of lung disease, set a price range on Monday for an initial public offering that would raise $60 million at the midpoint, advised by Cooley LLP and underwriters' counsel Davis Polk & Wardwell LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.